Tesla, Inc.

TSLA

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

**Signal Note: N/A – Not Biotech Relevant** This filing indicates a growth fund's entry into Tesla (automotive/energy), not a biotech asset.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 2,497Value: $1.1M

**Signal Note: N/A – Not Biotech Relevant** This filing indicates a growth fund's entry into Tesla (automotive/energy), not a biotech asset. No drug, indication, or clinical catalyst applies. This signals sector rotation toward capital-efficient industrial plays rather than biotech fundamentals and warrants no clinical or regulatory analysis.

More TSLA Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: